Clinical Trial Update: Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1 and Phase 2 trial investigating azithromycin as an immunomodulatory therapy for Graves' ophthalmopathy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Ophthalmopathy

Drugs mentioned

• Azithromycin (azithromycin)

Snippet

Sponsor: Rabin Medical Center | Conditions: Graves Ophthalmopathy | Phase 1, Phase 2 | Status: WITHDRAWN